Question Bank › Second engine igniting off the first

Second engine igniting off the first

Second engine igniting off the first: an unplanned-for adjacent revenue stream has started paying, and management is now

Calls Tested
434
Answered YES
11
Hit Rate
2.5%
rare by design

Supernus Pharmaceuticals, Inc. (SUPN) — this company's answers

NO on the Q3 2016 call 2016-11-18 D
The model's full reasoning — Q3 2016 call → NOWe need to determine if the transcript describes a second, distinct way of making money that emerged from existing operations, is already generating real paying business, and management is deliberately growing it. The transcript discusses: Trokendi XR and Oxtellar XR sales, pipeline (SPN-810, SPN-812), IP litigation, business development. There is also a royalty monetization transaction. The company had a royalty monetization transaction in 2014 where they received $30 million upfront in exchange for future royalties from Orenitram? Actually, the transcript mentions "royalty monetization transaction" and that it should have been recorded as debt. The company receives royalties from a counterparty? Let's read: "Royalties received by the counterparty to the royalty monetization transaction will now be recognized by Supernus as non-cash royalty revenue, and the $30 million of non-recourse debt will be reduced by the same amount, less non-cash implied interest expense to be recognized." So Supernus had monetized future royalties from some product (likely Orenitram, which is a product of United Therapeutics? Actually, Supernus had a royalty interest in Orenitram? The transcript mentions "Orenitram's ramp" in a question. But the key is: the company receives royalties from a product that is not its own? The royalty monetization transaction: Supernus sold its royalty stream to a counterparty for $30 million upfront. Now they are restating to record it as debt. So the royalties that the counterparty receives are now recognized by Supernus as non-cash royalty revenue, and the debt is reduced. So Supernus is still receiving royalties? Actually, the counterparty receives the royalties, but Supernus recognizes them as revenue and reduces the debt. So effectively, Supernus is earning royalty revenue from an existing asset (its royalty interest in some product). But is that a second avenue of making money? The company's core is selling its own products (Trokendi, Oxtellar). The royalty stream is from a product that Supernus had licensed or had a royalty interest in? This is not described as a new avenue that emerged from existing operations. It's a pre-existing royalty stream that was monetized. The restatement is about accounting treatment. The transcript does not describe management deliberately growing this royalty stream. It's just an accounting correction.

← Back to the full SUPN analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a SECOND, DISTINCT WAY OF MAKING MONEY has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional revenue avenue that grew out of what the company already does rather than a separate diversification - AND that this second avenue is ALREADY GENERATING REAL PAYING BUSINESS today while management is now deliberately putting effort or resources behind growing it? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent phenomenon with both halves present as a present-tense reality: (1) A SECOND EARNING AVENUE THAT GREW OUT OF THE FIRST. Management identifies an additional, distinguishable stream of business that arose from something the company already built or does - for example: monetizing a capability, technology, process, data, byproduct, or infrastructure that was originally created to serve the core business; the company's existing product or asset base opening a different kind of revenue (services on an installed base, licensing what it developed for itself, selling to a different side of its market, a spin-out offering born from internal tools, a byproduct or secondary output now being sold in its own right); or an offering originally built for one purpose now being sold as its own line of business. What matters is the ORIGIN - the second avenue leverages what already exists inside the company - and the DISTINCTNESS - management talks about it as its own stream of business, not just more sales of the same thing to the same buyers. (2) IT IS PAYING TODAY AND BEING FED. Management indicates that this second avenue is already producing real current revenue, orders, contracts, or paying customers in the recent period - actual money changing hands now, however small relative to the core - AND describes deliberate current effort to grow it: dedicating people, investment, capacity, or organizational focus to it; signing further deals in it; building it out; or explicitly treating it as a growth avenue the company is now pursuing on purpose. Answer NO if the company describes only one way of making money, however strong or fast-growing. NO if the additional avenue is only an idea, plan, pilot without paying customers, or an opportunity management says it could pursue someday. NO if the 'second stream' is ordinary cross-selling, upselling, product-line extensions, or new versions sold to the same customers in the same basic way. NO if the second business came chiefly from acquiring an unrelated company rather than emerging from the company's own operations. NO if management mentions the additional stream only in passing without conveying that it is real, paying, and being deliberately grown. NO if the company is a conglomerate or multi-segment business simply reporting its usual several segments. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
M Macy's, Inc. Q4 2022 2023-03-02 D
CMLS Cumulus Media Inc. Q3 2022 2022-10-28 D
GDRX GoodRx Holdings, Inc. Q2 2022 2022-08-08 F
SOPH SOPHiA GENETICS SA Q4 2021 2022-03-15 C
SLQT SelectQuote, Inc. Q2 2022 2022-02-07 F
LC LendingClub Corporation Q4 2021 2022-01-26 A
IRBT iRobot Corporation Q3 2021 2021-10-28 D
T AT&T Inc. Q3 2018 2018-10-24 C+
LRN Stride, Inc. Q1 2019 2018-10-23 B
MITK Mitek Systems, Inc. Q4 2017 2017-11-07 C+
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C

How the model reasoned

LRN · Q1 2019 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows career readiness as a distinct second revenue avenue that emerged directly from the existing MPS business: students already enrolled in Managed Public Schools are being moved into career readiness programs (over 5,000 students), and the initiative is built on the same platform, curriculum, and student base. Management explicitly describes it as a “career readiness line of business” and “robust career readiness business” that is already generating paying enrollments today while they are deliberately investing resources—dedicated executives, reallocation of funds, and plans to drive a major portion of next year’s enrollment growth.
M · Q4 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Macy’s Marketplace is explicitly described as a distinct new revenue avenue that emerged directly from their existing e-commerce operations and customer base (macys.com, cross-shoppers, and omnichannel platform). Jeff Gennette states it “captures incremental sales opportunity,” “drives a larger average order value,” “allows us to quickly move into new and adjacent categories without inventory risk,” and “attracts a new younger customer,” while management is actively scaling it by adding 2,000 brands in 2023 and launching Bloomingdale’s marketplace in the back half.
GDRX · Q2 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Pharma Manufacturer Solutions is the second distinct revenue avenue that emerged from GoodRx’s existing operations. Trevor explicitly states: “Our distinct ability to reach both consumers and providers continues to be recognized by manufacturers as evidenced by the strong growth.” This capability originated from the core prescription-transactions platform and user base 3 years earlier (when other offerings were only ~5% of revenue). In Q2 2022 it generated $26.6 million (102% YoY growth) and is already producing real paying business.

More from the question bank

Event-dense runwayThe leak is fixed: the company is keeping whBet-the-company financing already spent on hManagement is buying/committing capital at aScarcity of the company's own outputDemand pull is outrunning the plan for one sAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.